^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Acute Lymphocytic Leukemia |
| Drug: | cytarabine (DNA synthesis inhibitor, DNA-directed DNAP inhibitor) + methotrexate (THF dehydrogenase inhibitor, Dihydrofolic acid reductase inhibitor) + idarubicin (DNA replication inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Acute Lymphoblastic Leukemia: Other Recommended regimens…Cytarabine-containing regimens: eg, high-dose cytarabine, idarubicin, IT methotrexate
